Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BCNU' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 272 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Demir, A; Ozutemiz, O; Yildiz, C; Yuce, G; Tekesin, O; Ilter, T
      The effect of trimetazidine on intrahepatic cholestasis caused by carmustine in rats

      HEPATOLOGY RESEARCH
    2. Stuart, MJ; Chao, NS; Horning, SJ; Wong, RM; Negrin, RS; Johnston, LJ; Shizuru, JA; Long, GD; Blume, KG; Stockerl-Goldstein, KE; Goldstein, S
      Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    3. Kokkinakis, DM; Bocangel, DB; Schold, SC; Moschel, RC; Pegg, AE
      Thresholds of O-6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide

      CLINICAL CANCER RESEARCH
    4. Wiernik, PH; Leong, T; Oken, MM; Neiman, RS; Habermann, TM; Bennett, JM; Schuster, S; Glick, JH
      Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: A long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)

      LEUKEMIA & LYMPHOMA
    5. Choi, SM; Lee, SH; Yang, YS; Kim, BC; Kim, MK; Cho, KH
      5-fluorouracil-induced leukoencephalopathy in patients with breast cancer

      JOURNAL OF KOREAN MEDICAL SCIENCE
    6. Huncharek, M; Caubet, JF; McGarry, R
      Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials

      MELANOMA RESEARCH
    7. Egerer, G; Hegenbart, U; Salwender, H; Haas, R; Hahn, U; Schmier, JW; Ho, AD; Goldschmidt, H
      Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone

      SUPPORTIVE CARE IN CANCER
    8. Brandes, AA; Palmisano, V; Pasetto, LM; Basso, U; Monfardini, S
      High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults

      CANCER INVESTIGATION
    9. Thomas, D; Brada, M; Stenning, S
      Randomized trial of porcarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A medical research council trial

      JOURNAL OF CLINICAL ONCOLOGY
    10. Del Bufalo, D; Trisciuoglio, D; Biroccio, A; Marcocci, L; Buglioni, S; Candiloro, A; Scarsella, M; Leonetti, C; Zupi, G
      Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity

      JOURNAL OF CELLULAR BIOCHEMISTRY
    11. Tanaka, M; Shibui, S; Nomura, K; Nakanishi, Y
      Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: Results of a pilot study

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    12. Supko, JG; Garcia-Carbonero, R; Puchalski, TA; Malspeis, L
      Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    13. Westerhof, GR; Down, JD; Blokland, I; Wood, M; Boudewijn, A; Watson, AJ; McGown, AT; Ploemacher, RE; Margison, GP
      O-6-benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells

      EXPERIMENTAL HEMATOLOGY
    14. Brem, H; Gabikian, P
      Biodegradable polymer implants to treat brain tumors

      JOURNAL OF CONTROLLED RELEASE
    15. Mariani, L; Schroth, G; Wielepp, JP; Haldemann, A; Seiler, RW
      Intratumoral arteriovenous shunting in malignant gliomas

      NEUROSURGERY
    16. Gobin, YP; Cloughesy, TF; Chow, KL; Duckwiler, GR; Sayre, JW; Milanese, K; Vinuela, F
      Intraarterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery

      RADIOLOGY
    17. Kreklau, EL; Liu, NL; Li, ZH; Cornetta, K; Erickson, LC
      Comparison of single- versus double-bolus treatments of O-6-benzylguanine for depletion of O-6-methylguanine DNA methyltransferase (MGMT) activity invivo: Development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    18. Chen, ZP; Wang, ZM; Carter, CA; Alley, MC; Mohr, G; Panasci, LC
      Both extraneuronal monoamine transporter and O-6-methylguanine-DNA methyltransferase expression influence the antitumor efficacy of 2-chloroethyl-3-sarcosinamide-1-nitrosourea in human tumor xenografts

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Buckner, JC; Schomberg, PJ; McGinnis, WL; Cascino, TL; Scheithauer, BW; O'Fallon, JR; Morton, RF; Kuross, SA; Mailliard, JA; Hatfield, AK; Cole, JT; Steen, PD; Bernath, AM
      A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma

      CANCER
    20. Cao, TM; Negrin, RS; Stockerl-Goldstein, KE; Johnston, LJ; Shizuru, JA; Taylor, TL; Rizk, NW; Wong, RM; Blume, KG; Hu, WW
      Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    21. Schilsky, RL; Dolan, ME; Bertucci, D; Ewesuedo, RB; Vogelzang, NJ; Mani, S; Wilson, LR; Ratain, MJ
      Phase I clinical and pharmacological study of O-6-benzylguanine followed by carmustine in patients with advanced cancer

      CLINICAL CANCER RESEARCH
    22. van Os, R; Robinson, S; Sheridan, T; Mauch, PM
      Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal

      STEM CELLS
    23. Petrucci, MT; La Verde, G; Ribersani, M; Avvisati, G; Mandelli, F
      Intravenous melphalan and dexamethasone followed by lymphoblastoid alpha interferon in higher risk multiple myeloma patients

      LEUKEMIA & LYMPHOMA
    24. Fairbairn, LJ; Chinnasamy, N; Lashford, LS; Chinnasamy, D; Rafferty, JA
      Enhancing hemopoietic drug resistance: A rationale for reconsidering the clinical use of mitozolomide

      CANCER GENE THERAPY
    25. Emerich, DF; Winn, SR; Hu, YH; Marsh, J; Snodgrass, P; LaFreniere, D; Wiens, T; Hasler, BP; Bartus, RT
      Injectable chemotherapeutic microspheres and glioma I: Enhanced survival following implantation into the cavity wall of debulked tumors

      PHARMACEUTICAL RESEARCH
    26. Emerich, DF; Winn, SR; Snodgrass, P; LaFreniere, D; Agostino, M; Wiens, T; Xiong, H; Bartus, RT
      Injectable chemotherapeutic microspheres and glioma II: Enhanced survival following implantation into deep inoperable tumors

      PHARMACEUTICAL RESEARCH
    27. Coughlin, C; Scott, C; Langer, C; Coia, L; Curran, W; Rubin, P
      Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 gy) based on tumor volume (> 20 or <= 20 CM2, respectively) in the treatment of newly-diagnosedradiosurgery-ineligible glioblastoma multiforme patients

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    28. Rossi, SE; Erasmus, JJ; McAdams, HP; Sporn, TA; Goodman, PC
      Pulmonary drug toxicity: Radiologic and pathologic manifestations

      RADIOGRAPHICS
    29. Alessandrino, EP; Bernasconi, P; Colombo, A; Caldera, D; Martinelli, G; Vitulo, P; Malcovati, L; Nascimbene, C; Varettoni, M; Volpini, E; Klersy, C; Bernasconi, C
      Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies

      BONE MARROW TRANSPLANTATION
    30. Mackintosh, CA; Pegg, AE
      Effect of spermine synthase deficiency on polyamine biosynthesis and content in mice and embryonic fibroblasts, and the sensitivity of fibroblasts to1,3-bis-(2-chloroethyl)-N-nitrosourea

      BIOCHEMICAL JOURNAL
    31. Benoit, JP; Faisant, N; Venier-Julienne, MC; Menei, P
      Development of microspheres for neurological disorders: From basics to clinical applications

      JOURNAL OF CONTROLLED RELEASE
    32. Wakabayashi, T; Hatano, N; Kajita, Y; Yoshida, T; Mizuno, M; Taniguchi, K; Ohno, T; Nagasaka, T; Yoshida, J
      Initial and maintenance combination treatment with interferon-beta, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma

      JOURNAL OF NEURO-ONCOLOGY
    33. Kochi, M; Kitamura, I; Goto, T; Nishi, T; Takeshima, H; Saito, Y; Yamamoto, K; Kimura, T; Kino, T; Tada, K; Shiraishi, S; Uemura, S; Iwasaki, T; Kuratsu, J; Ushio, Y
      Randomized comparison of intra-arterial versus intravenous infusion of ACNU for newly diagnosed patients with glioblastoma

      JOURNAL OF NEURO-ONCOLOGY
    34. Boiardi, A; Eoli, M; Salmaggi, A; Pollo, B; Milanesi, I; Broggi, G; Silvani, A
      Cisplatin and BCNU chemotherapy for anaplastic oligoastrocytomas

      JOURNAL OF NEURO-ONCOLOGY
    35. Fels, C; Schafer, C; Huppe, B; Bahn, H; Heidecke, V; Kramm, CM; Lautenschlager, C; Rainov, NG
      Bcl-2 expression in higher-grade human glioma: A clinical and experimentalstudy

      JOURNAL OF NEURO-ONCOLOGY
    36. Gutin, PH; Posner, JB
      Neuro-oncology: Diagnosis and management of cerebral gliomas - Past, present, and future

      NEUROSURGERY
    37. Toft, NJ; Sanson, OJ; Brookes, RA; Arends, MJ; Wood, M; Margison, GP; Winton, DJ; Clarke, AR
      In vivo administration of O-6-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but doesinhibit P450-dependent activation of dacarbazine

      CARCINOGENESIS
    38. Thomson, KF; Sheehan-Dare, RA; Wilkinson, SM
      Allergic contact dermatitis from topical carmustine

      CONTACT DERMATITIS
    39. Prados, MD
      Future directions in the treatment of malignant gliomas with temozolomide

      SEMINARS IN ONCOLOGY
    40. Engelhard, HH
      The role of interstitial BCNU chemotherapy in the treatment of malignant glioma

      SURGICAL NEUROLOGY
    41. Kolotas, C; Birn, G; Hey, S; Strassmann, G; Martin, T; Vogt, HG; Baltas, D; Zamboglou, N
      Three-dimensional brachytherapy in malignant gliomas

      THREE-DIMENSIONAL RADIATION TREATMENT
    42. Cai, YN; Wu, MH; Xu-Welliver, M; Pegg, AE; Ludeman, SM; Dolan, ME
      Effect of O-6-benzylguanine on alkylating agent-induced toxicity and mutagenicity in Chinese hamster ovary cells expressing wild-type and mutant O-6-alkylguanine-DNA alkyltransferases

      CANCER RESEARCH
    43. Norman, SA; Rhodes, SN; Treasurywala, S; Hoelzinger, DB; Shapiro, JR; Scheck, AC
      Identification of transforming growth factor-beta 1-binding protein overexpression in carmustine-resistant glioma cells by mRNA differential display

      CANCER
    44. Hatano, N; Wakabayashi, T; Kajita, Y; Mizuno, M; Ohno, T; Nakayashiki, N; Takemura, A; Yoshida, J
      Efficacy of post operative adjuvant therapy with human interferon beta, MCNU and radiation (IMR) for malignant glioma: Comparison among three protocols

      ACTA NEUROCHIRURGICA
    45. Ophir, R; Moalem, G; Pecht, M; Shashoua, M; Rashid, G; Ben-Efraim, S; Trainin, N; Burstein, Y; Keisari, Y
      THF-gamma 2-mediated reduction of pulmonary metastases and augmentation ofimmunocompetence in C57BL/6 mice bearing B16-melanoma

      JOURNAL OF IMMUNOTHERAPY
    46. Long, LN; McCabe, DR; Dolan, ME
      Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection

      JOURNAL OF CHROMATOGRAPHY B
    47. Reese, JS; Davis, BM; Liu, LL; Gerson, SL
      Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells usingO-6-benzylguanine and temozolomide

      CLINICAL CANCER RESEARCH
    48. Koc, ON; Reese, JS; Davis, BM; Liu, L; Majczenko, KJ; Gerson, SL
      Delta MGMT-transduced bone marrow infusion increases tolerance to O-6-benzylguanine and 1,3-bis(2-chloroethy1)-1-nitrosourea and allows intensive therapy of 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant human colon cancer xenografts

      HUMAN GENE THERAPY
    49. Davis, BM; Roth, JC; Liu, LL; Xu-Welliver, M; Pegg, AE; Gerson, SL
      Characterization of the P140K, PVP(138-140)MLK, and G156A O-6-methylguanine-DNA methyltransferase mutants: Implications for drug resistance gene therapy

      HUMAN GENE THERAPY
    50. Kondziolka, D; Lunsford, LD; Flickinger, JC
      The radiobiology of radiosurgery

      NEUROSURGERY CLINICS OF NORTH AMERICA
    51. Rhee, CH; Ruan, SB; Chen, S; Chenchik, A; Levin, VA; Yung, AWK; Fuller, GN; Zhang, W
      Characterization of cellular pathways involved in glioblastoma response tothe chemotherapeutic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling

      ONCOLOGY REPORTS
    52. Biroccio, A; Del Bufalo, D; Ricca, A; D'Angelo, C; D'Orazi, G; Sacchi, A; Soddu, S; Zupi, G
      Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule

      GENE THERAPY
    53. da Rocha, AB; Mans, DRA; Bernard, EA; Ruschel, C; Logullo, AF; Wetmore, LA; Leyva, A; Schwartsmann, G
      Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to gamma-radiation and BCNU

      EUROPEAN JOURNAL OF CANCER
    54. Girgin, F; Tuzun, S; Demir, A; Kuralay, F; Ozutemiz, O; Tanyalcin, T
      Cytoprotective effects of trimetazidine in carmustine cholestasis

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    55. Chinnasamy, N; Rafferty, JA; Lashford, LS; Chinnasamy, D; Margison, GP; Thatcher, N; Dexter, TM; Fairbairn, LJ
      Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells - implications for chemoprotective gene therapy

      LEUKEMIA
    56. Yung, WKA; Prados, MD; Yaya-Tur, R; Rosenfeld, SS; Brada, M; Friedman, HS; Albright, R; Olson, J; Chang, SM; O'Neill, AM; Friedman, AH; Bruner, J; Yue, N; Dugan, M; Zaknoen, S; Levin, VA
      Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse

      JOURNAL OF CLINICAL ONCOLOGY
    57. Prados, MD; Scott, C; Curran, WJ; Nelson, DF; Leibel, S; Kramer, S
      Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplasticastrocytoma: A retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy

      JOURNAL OF CLINICAL ONCOLOGY
    58. Bethune, C; Blum, A; Geyer, JR; Silber, JR; Ho, RJY
      Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats

      PHARMACEUTICAL RESEARCH
    59. Suresh, MV; Kumar, CVS; Lal, JJ; Indira, M
      Impact of massive ascorbic acid supplementation on alcohol induced oxidative stress in guinea pigs

      TOXICOLOGY LETTERS
    60. Kleinberg, L; Grossman, SA; Piantadosi, S; Zeltzman, M; Wharam, M
      The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    61. Beauchesne, P; Soler, C; Rusch, P; Fotso, MJ; Duthel, R; Schmitt, T; Brunon, J
      Phase II study of a radiotherapy/etoposide combination for patients with newly malignant gliomas

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    62. Ozawa, T; Lu, RM; Hu, LJ; Lamborn, KR; Prados, MD; Deen, DF
      Radiopotentiation of human brain tumor cells by sodium phenylacetate

      CANCER LETTERS
    63. Johnson, DW; Cagnoni, PJ; Schossau, TM; Stemmer, SM; Grayeb, DEM; Baron, AE; Shpall, EJ; Bearman, SI; McDermitt, J; Jones, RB
      Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support

      BONE MARROW TRANSPLANTATION
    64. Napolitano, M; Keime-Guibert, F; Monjour, A; Lafitte, C; Ameri, A; Cornu, P; Broet, P; Delattre, JY
      Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study

      JOURNAL OF NEURO-ONCOLOGY
    65. Chao, KSC; Hsu, JSJ; Xu, J; Ezekiel, UR; Eves, E; Rosner, M; Hsu, CY
      Differential effect of cycloheximide on neuronal and glioma cells treated with chemotherapy and radiation

      JOURNAL OF NEURO-ONCOLOGY
    66. Bauman, GS; MacDonald, W; Moore, E; Ramsey, DA; Fisher, BJ; Amberger, VR; Del Maestro, RM
      Effects of radiation on a model of malignant glioma invasion

      JOURNAL OF NEURO-ONCOLOGY
    67. Abrey, LE; Rosenblum, MK; Papadopoulos, E; Childs, BH; Finlay, JL
      High dose chemotherapy with autologous stem cell rescue in adults with malignant primary brain tumors

      JOURNAL OF NEURO-ONCOLOGY
    68. Kuratsu, J; Arita, N; Kurisu, K; Uozumi, T; Hayakawa, T; Ushio, Y
      A phase II study of KRN8602(MX2), a novel morpholino anthracycline derivative, in patients with recurrent malignant glioma

      JOURNAL OF NEURO-ONCOLOGY
    69. Arafat, T; Patricia, H; Stefan, M; James, M; Naveed, C; Raphael, D; Patricia, R; Afif, I; Clemente, R; Allen, M; Magdy, S
      Toxicities related to intraarterial infusion of cisplatin and etoposide inpatients with brain tumors

      JOURNAL OF NEURO-ONCOLOGY
    70. Vigliani, MC; Duyckaerts, C; Hauw, JJ; Poisson, M; Magdelenat, H; Delattre, JY
      Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: A clinical and pathological study

      JOURNAL OF NEURO-ONCOLOGY
    71. Subach, BR; Witham, TF; Kondziolka, D; Lunsford, LD; Bozik, M; Schiff, D
      Morbidity and survival after 1,3-bis(2-chloroethyl)-1 nitrosourea wafer implantation for recurrent glioblastoma: A retrospective case matched cohort series

      NEUROSURGERY
    72. Rajkumar, SV; Buckner, JC; Schomberg, PJ; Pitot, HC; Ingle, JN; Cascino, TL
      Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas

      NEUROSURGERY
    73. Kreklau, EL; Kurpad, C; Williams, DA; Erickson, LC
      Prolonged inhibition of O-6-methylguanine DNA methyltransferase in human tumor cells by O-6-benzylguanine in vitro and in vivo

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    74. Maze, R; Kurpad, C; Pegg, AE; Erickson, LC; Williams, DA
      Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O-6-methylguanine DNA methyltransferase protects hematopoietic cellsagainst O-6-benzylguanine sensitization to chloroethylnitrosourea treatment

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    75. Folz, RJ; Elkordy, MA
      Coronavirus pneumonia following autologous bone marrow transplantation forbreast cancer

      CHEST
    76. Mlejnek, P; Kolman, A
      Effects of three epoxides, ethylene oxide, propylene oxide and epichlorohydrin, on cell cycle progression and cell death in human diploid fibroblasts

      CHEMICO-BIOLOGICAL INTERACTIONS
    77. Friedman, HS; Kerby, T; Fields, S; Zilisch, JE; Graden, D; McLendon, RE; Houghton, PJ; Arbuck, S; Cokgor, I; Friedman, AH
      Topotecan treatment of adults with primary malignant glioma

      CANCER
    78. Malhaire, JP; Lucas, B; Simon, H; Person, H; Dam-Hieu, P; Labat, JP
      Fotemustine (Muphoran (R)) in 22 patients with relapses of high-grade cerebral gliomas

      BULLETIN DU CANCER
    79. Kolotas, C; Birn, G; Baltas, D; Rogge, B; Ulrich, P; Zamboglou, N
      CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas

      BRITISH JOURNAL OF RADIOLOGY
    80. Belfi, CA; Chatterjee, S; Gosky, DM; Berger, SJ; Berger, NA
      Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    81. BERG SL; MURRY DJ; MCCULLY CL; GODWIN K; BALIS FM
      PHARMACOKINETICS OF O-6-BENZYLGUANINE AND ITS ACTIVE METABOLITE 8-OXO-O-6-BENZYLGUANINE IN PLASMA AND CEREBROSPINAL-FLUID AFTER INTRATHECALADMINISTRATION OF O-6-BENZYLGUANINE IN THE NONHUMAN PRIMATE

      Clinical cancer research
    82. WILCZYNSKI SW; ERASMUS JJ; PETROS WP; VREDENBURGH JJ; FOLZ RJ
      DELAYED PULMONARY TOXICITY SYNDROME FOLLOWING HIGH-DOSE CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION FOR BREAST-CANCER

      American journal of respiratory and critical care medicine
    83. KERSIENE R; MAROZIENE A; KLIUKIENE R; ANUSEVICIUS Z; DIDZIAPETRIENE J; CENAS N
      MODULATION OF ERYTHROCYTE PHOTOHEMOLYSIS RATE BY GLUTATHIONE-REDUCTASE INACTIVATING ALKYLATING-AGENTS

      Biochemistry and molecular biology international
    84. CHINNASAMY N; RAFFERTY JA; HICKSON I; LASHFORD LS; LONGHURST SJ; THATCHER N; MARGISON GP; DEXTER TM; FAIRBAIRN LJ
      CHEMOPROTECTIVE GENE-TRANSFER-II - MULTILINEAGE IN-VIVO PROTECTION OFHEMATOPOIESIS AGAINST THE EFFECTS OF AN ANTITUMOR AGENT BY EXPRESSIONOF A MUTANT HUMAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE

      Gene therapy
    85. STABA MJ; MAUCERI HJ; KUFE DW; HALLAHAN DE; WEICHSELBAUM RR
      ADENOVIRAL TNF-ALPHA GENE-THERAPY AND RADIATION-DAMAGE TUMOR VASCULATURE IN A HUMAN-MALIGNANT GLIOMA XENOGRAFT

      Gene therapy
    86. GUNDERSEN S; LOTE K; WATNE K
      A RETROSPECTIVE STUDY OF THE VALUE OF CHEMOTHERAPY AS ADJUVANT THERAPY TO SURGERY AND RADIOTHERAPY IN GRADE-3 AND GRADE-4 GLIOMAS

      European journal of cancer
    87. HOSLI P; SAPPINO AP; DETRIBOLET N; DIETRICH PY
      MALIGNANT GLIOMA - SHOULD CHEMOTHERAPY BE OVERTHROWN BY EXPERIMENTAL TREATMENTS

      Annals of oncology
    88. SCHMID E; ELBENNA J; GALTER D; KLEIN G; DROGE W
      REDOX PRIMING OF THE INSULIN-RECEPTOR BETA-CHAIN ASSOCIATED WITH ALTERED TYROSINE KINASE-ACTIVITY AND INSULIN RESPONSIVENESS IN THE ABSENCEOF TYROSINE AUTOPHOSPHORYLATION

      The FASEB journal
    89. DOLAN ME; ROY SK; FASANMADE AA; PARAS PR; SCHILSKY RL; RATAIN MJ
      O-6-BENZYLGUANINE IN HUMANS - METABOLIC, PHARMACOKINETIC, AND PHARMACODYNAMIC FINDINGS

      Journal of clinical oncology
    90. TURHAL N; HENEHAN MD; KAPLAN KL
      MULTIPLE-MYELOMA - A PATIENT WITH UNUSUAL FEATURES INCLUDING INTRACRANIAL AND MENINGEAL INVOLVEMENT, TESTICULAR INVOLVEMENT, ORGANOMEGALY, AND PLASMA-CELL LEUKEMIA

      American journal of hematology
    91. SCOTT CB; SCARANTINO C; URTASUN R; MOVSAS B; JONES CU; SIMPSON JR; FISCHBACH AJ; CURRAN WJ
      VALIDATION AND PREDICTIVE POWER OF RADIATION-THERAPY ONCOLOGY GROUP (RTOG) RECURSIVE PARTITIONING ANALYSIS CLASSES FOR MALIGNANT GLIOMA PATIENTS - A REPORT USING RTOG-90-06

      International journal of radiation oncology, biology, physics
    92. CHANG EL; LOEFFLER JS; RIESE NE; WEN PY; ALEXANDER E; BLACK PM; COLEMAN CN
      SURVIVAL RESULTS FROM A PHASE-I STUDY OF ETANIDAZOLE (SR2508) AND RADIOTHERAPY IN PATIENTS WITH MALIGNANT GLIOMA

      International journal of radiation oncology, biology, physics
    93. Rajkumar, SV; Buckner, JC; Schomberg, PJ; Reid, JM; Bagniewski, PJ; Ames, MM; Cascino, TL; Marks, RS
      Phase I and pharmacokinetic study of preirradiation chemotherapy with BCNU, cisplatin, etoposide, and accelerated radiation therapy in patients with high-grade glioma

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    94. Paccapelo, A; Piana, C; Rychlicki, F; Recchioni, MA; Salvolini, U; Ducati, A; Bonsignori, M
      Treatment of malignant gliomas: A new approach

      TUMORI
    95. PAPADOPOULOS KP; GARVIN JH; FETELL M; VAHDAT LT; GARRETT TJ; SAVAGE DG; BALMACEDA C; BRUCE J; SISTI M; ISAACSON S; DELAPAZ R; HAWKS R; BAGIELLA E; ANTMAN KH; HESDORFFER CS
      HIGH-DOSE THIOTEPA AND ETOPOSIDE-BASED REGIMENS WITH AUTOLOGOUS HEMATOPOIETIC SUPPORT FOR HIGH-RISK OR RECURRENT CNS TUMORS IN CHILDREN ANDADULTS

      Bone marrow transplantation
    96. HUNCHAREK M
      METAANALYTIC REEVALUATION OF MISONIDAZOLE IN THE TREATMENT OF HIGH-GRADE ASTROCYTOMA

      Anticancer research
    97. Huncharek, M; Muscat, J; Geschwind, JF
      Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis

      ANTICANCER RESEARCH
    98. HILDEBRAND J; DEWITTE O; SAHMOUD T
      RESPONSE OF RECURRENT GLIOBLASTOMA AND ANAPLASTIC ASTROCYTOMA TO DIBROMODULCITOL, BCNU AND PROCARBAZINE - A PHASE-II STUDY

      Journal of neuro-oncology
    99. DROPCHO EJ; ROSENFELD SS; VITEK J; GUTHRIE BL; MORAWETZ RB
      PHASE-II STUDY OF INTRACAROTID OR SELECTIVE INTRACEREBRAL INFUSION OFCISPLATIN FOR TREATMENT OF RECURRENT ANAPLASTIC GLIOMAS

      Journal of neuro-oncology
    100. JAKACKI RI; JAMISON C; MATHEWS VP; HEILMAN DK; DROPCHO E; CORNETTA K; MACDONALD DR; WILLIAMS DA
      DOSE-INTENSIFICATION OF PROCARBAZINE, CCNU (LOMUSTINE), VINCRISTINE (PCV) WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN YOUNG-PATIENTS WITH GLIOMAS

      Medical and pediatric oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 11:03:32